{
 "drug": "Phenobarbital Tablet",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "10/31/2025",
 "dayN": 298,
 "cat": "Analgesia/Addiction",
 "companies": [
  "Endo Pharmaceuticals, Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5166-32",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5166",
     "0603-5165",
     "0603-5167",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-32)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5168-32",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5168",
     "0603-5165",
     "0603-5166",
     "0603-5167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-32)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5165-21",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5165",
     "0603-5166",
     "0603-5167",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-21)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5165-32",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5165",
     "0603-5166",
     "0603-5167",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 16.2 mg (NDC 0603-5165-32)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5167-32",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5167",
     "0603-5165",
     "0603-5166",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-32)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5166-21",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5166",
     "0603-5165",
     "0603-5167",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 32.4 mg (NDC 0603-5166-21)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5167-21",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5167",
     "0603-5165",
     "0603-5166",
     "0603-5168"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 64.8 mg (NDC 0603-5167-21)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  },
  {
   "discontinued_date": "10/31/2025",
   "update_type": "New",
   "initial_posting_date": "10/31/2025",
   "package_ndc": "0603-5168-21",
   "generic_name": "Phenobarbital Tablet",
   "contact_info": "800-828-9393",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "brand_name": [
     "PHENOBARBITAL"
    ],
    "generic_name": [
     "PHENOBARBITAL"
    ],
    "manufacturer_name": [
     "Par Health USA, LLC"
    ],
    "product_ndc": [
     "0603-5168",
     "0603-5165",
     "0603-5166",
     "0603-5167"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "PHENOBARBITAL"
    ],
    "rxcui": [
     "198086",
     "199164",
     "199167",
     "199168"
    ],
    "spl_id": [
     "f8c5136e-e35c-4425-8d49-b7f92c827b42"
    ],
    "spl_set_id": [
     "069b92ce-0061-4724-8c25-08d8596770a2"
    ],
    "package_ndc": [
     "0603-5165-21",
     "0603-5165-32",
     "0603-5166-16",
     "0603-5166-20",
     "0603-5166-02",
     "0603-5166-21",
     "0603-5166-22",
     "0603-5166-32",
     "0603-5167-21",
     "0603-5167-32",
     "0603-5168-21",
     "0603-5168-32"
    ],
    "unii": [
     "YQE403BP4D"
    ]
   },
   "update_date": "10/31/2025",
   "therapeutic_category": [
    "Analgesia/Addiction",
    "Neurology",
    "Other"
   ],
   "dosage_form": "Tablet",
   "presentation": "Phenobarbital, Tablet, 97.2 mg (NDC 0603-5168-21)",
   "company_name": "Endo Pharmaceuticals, Inc.",
   "status": "To Be Discontinued"
  }
 ]
}